Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

23.55
Delayed Data
As of Jul 31
 +0.03 / +0.13%
Today’s Change
12.11
Today|||52-Week Range
32.82
+29.04%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 37.00, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a +57.11% increase from the last price of 23.55.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$501.4K
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.03%
 
 
 
 
 
 
Growthannually -6.89%
 
 
 
 
 
 

Sales

Growthquarterly 3.16%
 
 
 
 
 
 
Growthannually -39.14%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.